Ophthalmology Search
Ophthalmology Ophthalmology
primary%20open-angle%20glaucoma
PRIMARY OPEN-ANGLE GLAUCOMA
Primary open-angle glaucoma (POAG) is a chronic, progressive, usually bilateral disease of the eye with an insidious onset.
It is most often characterized by optic nerve damage, defects in the retinal fiber layer and subsequent visual field loss in the absence of underlying ocular disease or congenital abnormalities.
It is generally asymptomatic until it has caused a significant loss of visual field.
Occasionally, patients with very high intraocular pressure may complain of nonspecific headache, discomfort, intermittent blurring of vision or even halos caused by corneal edema.

Primary Open-Angle Glaucoma Drug Information

Drug Information

Indication: Decreased IOP in adult patients w/ open-angle glaucoma or ocular HTN for whom monotherapy provides insufficien...

Indication: Elevated IOP in ocular HTN or open-angle glaucoma.

Indication: Chronic open-angle glaucoma, ocular HTN.

Indication: Elevated IOP in patients w/ ocular HTN & open-angle glaucoma when concomitant therapy is appropriate.

Indication: Decrease of IOP in adults w/ open-angle glaucoma or ocular HTN who are insufficiently responsive to topical &b...

Indication: Elevated IOP in patients w/ ocular HTN or open-angle glaucoma.

Indication: Decrease of elevated IOP in adults w/ ocular HTN or open-angle glaucoma.

Indication: Reduction of elevated IOP in patients w/ open-angle glaucoma, chronic angle closure glaucoma & ocular HTN;...

Indication: Reduction of IOP in patients w/ primary open-angle glaucoma or ocular HTN.

Indication: Reduction of IOP in patients w/ primary open-angle glaucoma or ocular HTN.

1  /  3
1  /  3
Editor's Recommendations
Most Read Articles
Yoga helps in type 2 diabetes
6 days ago
Regular practice of yoga postures confers benefits for glucose control, oxidative stress, inflammatory response, and sleep quality in patients with type 2 diabetes, a study has found.
Product Highlight - ADACEL
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Spotlight on multidrug-resistant gram-negative infections: New developments for an old problem
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Central obesity bears risk of breast cancer
09 Jan 2021
Women with central adiposity, regardless of menopausal status, are at risk of developing breast cancer, according to a study.